Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 113 matching records.
113 results — page 1 of 5
- Level DAnimal StudyPubMed
Single-cell transcriptomic profiling identifies therapeutic subpopulations of adipose-derived mesenchymal stromal cells for human keloid management.
Animal Study on Chronic Wound, Scar, published in Mol Cell Biochem (2026) — summary generated from the PubMed abstract.
- 2026
Mol Cell Biochem - Level DNarrative ReviewEurope PMC
Engineered Mesenchymal Stromal Cells in Oncology: Navigating Between Therapeutic Delivery and Tumor Promotion
Narrative Review on Systemic / IV, published in Genes (Basel) (2026) — summary generated from the PubMed abstract.
- 2026
Genes (Basel) - Level DNarrative ReviewEurope PMC
Activation of Nrf2 with natural flavonoids and mesenchymal stromal/stem cells: mechanisms and therapeutic potential for inflammatory diseases
Narrative Review on Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther - Level AMeta-analysisEurope PMC
Therapeutic potential of mesenchymal stromal cells in COVID-19: a meta-analysis of clinical trials conducted since the pandemic onset
Meta-analysis with a reported sample of 1080 on Chronic Inflammation, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
- n = 1080
Stem Cell Res Ther - Level DNarrative ReviewEurope PMC
Mesenchymal Stromal Cells in Knee Osteoarthritis: A Review of Nomenclature, Criteria, and Therapeutic Mechanisms
Narrative Review on Knee Osteoarthritis, Osteoarthritis, Immune Modulation, published in Ther Clin Risk Manag (2026) — summary generated from the PubMed abstract.
- 2026
Ther Clin Risk Manag - Level DAnimal StudyPubMed
Therapeutic potential of adipose-derived mesenchymal stem/stromal cells conditioned medium versus adipose-derived mesenchymal stem/stromal cells on treatment of polycystic ovary In-vivo.
Animal Study on Type 2 Diabetes, published in Tissue Cell (2026) — summary generated from the PubMed abstract.
- 2026
Tissue Cell - Level BClinical TrialPubMed
Combination of rapamycin and adipose-derived mesenchymal stromal cells enhances therapeutic potential for osteoarthritis.
Clinical Trial on Osteoarthritis, Chronic Inflammation, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther7 citations - Level DAnimal StudyPubMed
The therapeutic potential of mesenchymal stromal cell secretome in treating spontaneous chronic corneal epithelial defects in dogs.
Animal Study, published in Res Vet Sci (2025) — summary generated from the PubMed abstract.
- 2025
Res Vet Sci - Level DNarrative ReviewPubMed
Mesenchymal stem/stromal cells-derived exosomes: possible therapeutic mechanism in inflammatory bowel disease.
Narrative Review on Ligament Injury, Chronic Inflammation, Immune Modulation, published in Hum Cell (2025) — summary generated from the PubMed abstract.
- 2025
Hum Cell - Level DAnimal StudyEurope PMC
Therapeutic potential of human mesenchymal stromal cell-derived mitochondria in a rat model of surgical digestive fistula
Animal Study on Chronic Wound, Autoimmune Research, published in Sci Rep (2025) — summary generated from the PubMed abstract.
- 2025
Sci Rep2 citations - Level ASystematic ReviewEurope PMC
A systematic review of preclinical studies on therapeutic potential of mesenchymal stem/stromal cells and their secretome in bacterial infections
Systematic Review, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther3 citations - Level CCase Report / SeriesPubMed
Therapeutic application of canine adipose tissue-derived mesenchymal stromal cells in a dog with refractory immune-mediated thrombocytopenia, with diabetic ketoacidosis, and gastrointestinal bleeding induced by immunosup
Case Report / Series on Systemic / IV, published in Vet Res Commun (2025) — summary generated from the PubMed abstract.
- 2025
Vet Res Commun - Level DAnimal StudyPubMed
Freeze-Dried, Not Frozen: Lyophilized Mesenchymal Stromal Cell-Derived Extracellular Vesicles and Therapeutic Function in Neuroinflammatory Models.
Animal Study on Immune Modulation, published in J Am Coll Surg (2025) — summary generated from the PubMed abstract.
- 2025
J Am Coll Surg - Level DNarrative ReviewPubMed
Advances in human amniotic placenta membrane-derived mesenchymal stromal cells (hAMSCs) for regenerative medicine: enhancing therapeutic potential with biomaterials and scaffolds.
Narrative Review on Immune Modulation, published in Front Bioeng Biotechnol (2025) — summary generated from the PubMed abstract.
- 2025
Front Bioeng Biotechnol - Level DAnimal StudyPubMed
Therapeutic effects of mesenchymal stromal cell secretome in liver fibrosis with acute lung injury.
Animal Study on Systemic / IV, published in Exp Biol Med (Maywood) (2025) — summary generated from the PubMed abstract.
- 2025
Exp Biol Med (Maywood) - Level CProspective StudyPubMed
Implantation of human mesenchymal stromal cell pellet for therapeutic angiogenesis.
Prospective Study with a reported sample of 237 on Face & Skin, Systemic / IV, published in Cytotherapy (2025) — summary generated from the PubMed abstract.
- 2025
- n = 237
Cytotherapy2 citations - Level DNarrative ReviewEurope PMC
Mesenchymal Stromal/Stem Cells (MSCs) in Cancer Therapy: Advanced Therapeutic Strategies Towards Future Clinical Translation
Narrative Review, published in Molecules (2025) — summary generated from the PubMed abstract.
- 2025
Molecules3 citations - Level BClinical TrialPubMed
Enhancing the clinical potential: Quality assessment of adipose tissue-derived Mesenchymal Stem/Stromal Cells for therapeutic use.
Clinical Trial on Neuroinflammation, published in Adv Med Sci (2025) — summary generated from the PubMed abstract.
- 2025
Adv Med Sci - Level DNarrative ReviewPubMed
Mesenchymal stromal cells (MSCs) as a therapeutic agent of inflammatory disease and infectious COVID-19 virus: live or dead mesenchymal?
Narrative Review with a reported sample of 19 on Chronic Inflammation, Autoimmune Research, published in Mol Biol Rep (2024) — summary generated from the PubMed abstract.
- 2024
- n = 19
Mol Biol Rep - Level DLaboratory StudyPubMed
Optimizing cryopreservation conditions for use of fucosylated human mesenchymal stromal cells in anti-inflammatory/immunomodulatory therapeutics.
Laboratory Study on Chronic Inflammation, Immune Modulation, published in Front Immunol (2024) — summary generated from the PubMed abstract.
- 2024
Front Immunol - Level DLaboratory StudyPubMed
Proteomic analysis and functional validation reveal distinct therapeutic capabilities related to priming of mesenchymal stromal/stem cells with IFN-γ and hypoxia: potential implications for their clinical use.
Laboratory Study, published in Front Cell Dev Biol (2024) — summary generated from the PubMed abstract.
- 2024
Front Cell Dev Biol - Level BClinical TrialEurope PMC
Mesenchymal Stromal Cell-Based Products: Challenges and Clinical Therapeutic Options
Clinical Trial, published in Int J Mol Sci (2024) — summary generated from the PubMed abstract.
- 2024
Int J Mol Sci20 citations - Level AMeta-analysisPubMed
Preclinical Therapeutic Efficacy of Extracellular Vesicles Derived from Adipose-Derived Mesenchymal Stromal/Stem Cells in Diabetic Wounds: a Systematic Review and Meta-Analysis.
Meta-analysis on Diabetic Foot, Chronic Wound, published in Stem Cell Rev Rep (2024) — summary generated from the PubMed abstract.
- 2024
Stem Cell Rev Rep - Level DNarrative ReviewEurope PMC
The Therapeutic Potential of Human Umbilical Cord Mesenchymal Stromal Cells Derived Exosomes for Wound Healing: Harnessing Exosomes as a Cell-free Therapy
Narrative Review on Chronic Wound, Scar, published in J Stem Cells Regen Med (2024) — summary generated from the PubMed abstract.
- 2024
J Stem Cells Regen Med7 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406